Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.04 0.3
mRNA Merck60 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA Axitinib CTRPv2 pan-cancer AAC 0.038 0.3
mRNA GW843682X GDSC1000 pan-cancer AAC -0.06 0.3
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA pandacostat CTRPv2 pan-cancer AAC 0.041 0.3
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.032 0.3
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.3
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.036 0.3
Download CSV